+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

The language of the tumour-immune relationship



The language of the tumour-immune relationship



Chronica Dermatologica 2(3): 364-365




(PDF emailed within 1 workday: $29.90)

Accession: 033856997

Download citation: RISBibTeXText


Related references

An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemia. Cancer Immunology, ImmunoTherapy 55(8): 1017-1024, 2006

Host--tumour relationship. XX. The hexosamine content of the tumour as a marker of relations between the tumour stroma and tumour cells. Neoplasma 12(4): 373-378, 1965

Exploring the Relationship between Native Language Skills and Foreign Language Learning in Children with Developmental Language Disorders. Clinical Linguistics and Phonetics 2019: 1-13, 2019

The relationship between mathematics and language: academic implications for children with specific language impairment and English language learners. Language, Speech, and Hearing Services in Schools 45(3): 220-233, 2014

Language Skill Mediates the Relationship Between Language Load and Articulatory Variability in Children With Language and Speech Sound Disorders. Journal of Speech, Language, and Hearing Research 2018: 1-13, 2018

The relationship of immune status to the efficacy of immunotherapy in preventing tumour recurrence in mice. British Journal of Cancer 30(4): 289-296, 1974

Relationship of maternal language to language development and language delay of children. American Journal of Mental Deficiency 86(4): 391-398, 1982

Host tumour relationship in stomach cancer--correlation of histological criteria with tests of immune competence. British Journal of Cancer 32(2): 243-243, 1975

Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC. Bmc Cancer 18(1): 123, 2018

Intracapillary HbO2 saturations in murine tumours and human tumour xenografts measured by cryospectrophotometry: relationship to tumour volume, tumour pH and fraction of radiobiologically hypoxic cells. British Journal of Cancer 57(5): 494-502, 1988

Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity. Cancer Immunology, ImmunoTherapy 62(5): 863-873, 2013

H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response. Experimental and Clinical Immunogenetics 6(3): 204-218, 1989

Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study. Annals of the Rheumatic Diseases 77(3): 393-398, 2017

Resistance to tumour challenge after tumour laser thermotherapy is associated with a cellular immune response. British Journal of Cancer 93(4): 435-440, 2005

Treatment of a low immunogenic experimental tumour with alloactivated or tumour-immune lymphocytes. Biochimica et Biophysica Acta 907(2): 163-174, 1987